Skip to main content
    A

    Aveanna Healthcare Holdings Inc (AVAH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $11.63
    +0.13 (+1.13%)

    Market Cap: $2.51B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Aveanna Healthcare Holdings Inc (AVAH) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Aveanna Healthcare Holdings (AVAH) trades at 14.9x trailing earnings and 1.0x sales. Its P/S of 1.0x is above its 5-year median of 0.4x. Its forward P/E is 12.0x. The median P/E across 11 similar companies is 28.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 24.2% higher over the next year. Its free cash flow yield is 7.4%.

    MultipleValue
    P/E (trailing)14.9x
    Forward P/E12.0x
    Price to sales1.0x
    Price to book7.9x
    EV/EBITDA11.4x
    Price to FCF13.5x
    EV/FCF20.1x
    PEGN/A
    FCF yield7.4%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S1.0x0.4xN/A
    Medians of month-end values through Oct 2026: 58 months (5-year).

    Valuation History

    Over the 4 of the 5 year ends shown that have a P/E, its P/E ranged from 14.1x in 2025 to 91.4x in 2024. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$8.1714.1x0.7x9.0x
    2024$4.5791.4x0.4xN/A
    2023$2.68N/A0.3xN/A
    2022$0.7878.0xN/AN/A
    2021$7.4019.0x0.8x2.2x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About AVAH

    What is AVAH's forward P/E ratio?

    Aveanna Healthcare Holdings has a forward P/E ratio of 12.0x.

    Is AVAH stock overvalued?

    GNG's valuation label for AVAH is Overvalued. Its P/E of 14.9x compares with a median of 28.8x across 11 similar companies.

    What is AVAH's price to sales ratio?

    Aveanna Healthcare Holdings has a price to sales ratio of 1.0x.